1. Home
  2. NAMS vs POWL Comparison

NAMS vs POWL Comparison

Compare NAMS & POWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • POWL
  • Stock Information
  • Founded
  • NAMS 2019
  • POWL 1947
  • Country
  • NAMS Netherlands
  • POWL United States
  • Employees
  • NAMS N/A
  • POWL N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • POWL Electrical Products
  • Sector
  • NAMS Health Care
  • POWL Energy
  • Exchange
  • NAMS Nasdaq
  • POWL Nasdaq
  • Market Cap
  • NAMS 2.5B
  • POWL 2.1B
  • IPO Year
  • NAMS N/A
  • POWL N/A
  • Fundamental
  • Price
  • NAMS $23.60
  • POWL $248.37
  • Analyst Decision
  • NAMS Strong Buy
  • POWL Strong Buy
  • Analyst Count
  • NAMS 9
  • POWL 1
  • Target Price
  • NAMS $41.11
  • POWL $312.00
  • AVG Volume (30 Days)
  • NAMS 844.8K
  • POWL 286.5K
  • Earning Date
  • NAMS 08-06-2025
  • POWL 07-29-2025
  • Dividend Yield
  • NAMS N/A
  • POWL 0.43%
  • EPS Growth
  • NAMS N/A
  • POWL 68.79
  • EPS
  • NAMS N/A
  • POWL 14.23
  • Revenue
  • NAMS $47,140,000.00
  • POWL $1,083,293,000.00
  • Revenue This Year
  • NAMS N/A
  • POWL $11.52
  • Revenue Next Year
  • NAMS N/A
  • POWL $5.05
  • P/E Ratio
  • NAMS N/A
  • POWL $17.48
  • Revenue Growth
  • NAMS 586.97
  • POWL 27.43
  • 52 Week Low
  • NAMS $14.06
  • POWL $127.41
  • 52 Week High
  • NAMS $27.29
  • POWL $364.98
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 67.01
  • POWL 72.25
  • Support Level
  • NAMS $22.00
  • POWL $212.39
  • Resistance Level
  • NAMS $24.82
  • POWL $237.74
  • Average True Range (ATR)
  • NAMS 1.21
  • POWL 9.38
  • MACD
  • NAMS 0.25
  • POWL 2.00
  • Stochastic Oscillator
  • NAMS 77.98
  • POWL 92.26

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

Share on Social Networks: